GTDDX
Price
$34.75
Change
+$0.31 (+0.90%)
Updated
Dec 26 closing price
Net Assets
1.05B
RNWHX
Price
$92.12
Change
+$0.22 (+0.24%)
Updated
Dec 26 closing price
Net Assets
75.3B
Interact to see
Advertisement

GTDDX vs RNWHX

Header iconGTDDX vs RNWHX Comparison
Open Charts GTDDX vs RNWHXBanner chart's image
Invesco Emerging Markets ex-China A
Price$34.75
Change+$0.31 (+0.90%)
VolumeN/A
Net Assets1.05B
American Funds New World R5E
Price$92.12
Change+$0.22 (+0.24%)
VolumeN/A
Net Assets75.3B
GTDDX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
GTDDX vs. RNWHX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTDDX is a StrongBuy and RNWHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 75.3B vs. GTDDX (1.05B). GTDDX (0.93) and RNWHX (0.91) have matching dividends . GTDDX was incepted earlier than RNWHX: GTDDX (32 years) vs RNWHX (10 years). GTDDX (1.39) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 37.00 vs. GTDDX (20.00). RNWHX has a lower initial minimum investment than GTDDX: RNWHX (250) vs GTDDX (1000). RNWHX annual gain was more profitable for investors over the last year : 19.48 vs. GTDDX (4.48). RNWHX return over 5 years is better than : 11.64 vs. GTDDX (-13.26).
GTDDXRNWHXGTDDX / RNWHX
Total Expense Ratio1.390.72193%
Annual Report Gross Expense Ratio1.390.72193%
Fund Existence32 years10 years-
Gain YTD6.13921.17929%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRA250N/A-
Net Assets1.05B75.3B1%
Annual Yield % from dividends0.930.91103%
Returns for 1 year4.4819.4823%
Returns for 3 years13.9044.2731%
Returns for 5 years-13.2611.64-114%
Returns for 10 years51.7989.7358%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.750.05
+2.94%
Innate Pharma SA
INTA47.670.38
+0.80%
Intapp
CIEN241.681.40
+0.58%
Ciena Corp
NCNA3.31-0.03
-0.90%
NuCana plc
VIR6.00-0.11
-1.80%
Vir Biotechnology